We serve Tris(tetrabutylammonium) hydrogen pyrophosphate,Pyrophosphoric acid tris(tetrabutylammonium) salt,Tetrabutylammonium pyrophosphate (3:1) CAS:76947-02-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Storage conditions: 2-8ºC
| Items of Analysis | Standard of Analysis | Test Results |
| Appearance | White powder | Conform |
| Moisture | ≤0.5% | 0.16% |
| Assay | ≥98% | 98.57% |
| Conclusion | Conforms to Factory Standard | |
Contact us for information like Tris(tetrabutylammonium) hydrogen pyrophosphate,Pyrophosphoric acid tris(tetrabutylammonium) salt,Tetrabutylammonium pyrophosphate (3:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Tris(tetrabutylammonium) hydrogen pyrophosphate,Pyrophosphoric acid tris(tetrabutylammonium) salt,Tetrabutylammonium pyrophosphate (3:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Tris(tetrabutylammonium) hydrogen pyrophosphate,Pyrophosphoric acid tris(tetrabutylammonium) salt,Tetrabutylammonium pyrophosphate (3:1) Use and application,Tris(tetrabutylammonium) hydrogen pyrophosphate,Pyrophosphoric acid tris(tetrabutylammonium) salt,Tetrabutylammonium pyrophosphate (3:1) technical grade,usp/ep/jp grade.
Related News: Any drug or medication is composed of two components.(3-(ethylthio)-2,2-dimethyl-3-oxopropanoyl)glycine manufacturer Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia. Pentacosane, 5,11-dimethyl- supplier In the process of fine chemical industry transfer, intermediates are a very important category, and they are also the main link for China to undertake transfers.Benzyl-[(R)-2-((R)-hydroxy-phenyl-methyl)-3-oxo-3-(2-thioxo-thiazolidin-3-yl)-propyl]-carbamic acid benzyl ester vendor With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved.A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA’s concerns.
